Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	124,450,304 L.L
R03AK12	ZEPHIRUS	B	Salmeterol - 20mcg, Budesonide - 240mcg		Capsule, inhalation	1,678,459 L.L
C05BX51	DOXIPROCT	B	Calcium dobesilate - 4%, Lidocaine HCl - 2%		Ointment	610,104 L.L
C09CA07	MICARDIS	B	Telmisartan - 40mg	40mg	Tablet	760,615 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 500mg	500mg	Tablet, film coated, modified release	1,226,096 L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	124,450,304 L.L
L04AA37	OLUMIANT	B	Baricitinib - 2mg	2mg	Tablet, film coated	68,053,864 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
A09AA02	CREON 10,000	B	Pancreatin protease - 600FIP-U, Pancreatin amylase - 8,000FIP-U, Pancreatin lipase - 10,000FIP-U		Capsule	1,835,689 L.L
C05BX51	DOXIPROCT PLUS	B	Calcium dobesilate - 4%, Dexamethasone acetate - 0.0025%, Lidocaine HCl - 2%		Ointment	489,159 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 750mg	750mg	Tablet, film coated, modified release	1,555,018 L.L
L01EX09	OFEV	B	Nintedanib - 100mg	100mg	Capsule, soft	100,972,184 L.L
L04AA37	OLUMIANT	B	Baricitinib - 4mg	4mg	Tablet, film coated	68,053,864 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
L01XG02	KYPROLIS	B	Carfilzomib - 60mg	60mg	Injectable powder for solution	L.L
A02BC04	PARIET	B	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	779,429 L.L
A09AA02	CREON 25,000	B	Pancreatin protease - 1000FIP-U, Pancreatin amylase - 18000FIP-U, Pancreatin lipase - 25000FIP-U		Capsule	4,598,629 L.L
C05CA03	DIOVENOR 600	B	Diosmin - 600mg	600mg	Tablet, film coated	1,089,856 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 125mg/5ml	125mg/5ml	Granules for suspension	487,623 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	201,946,695 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	15,102,158 L.L
N05AD01	HALDOL	B	Haloperidol - 5mg	5mg	Tablet	231,141 L.L
R03AL01	ATROVENT COMP. HFA	B	Fenoterol Hydrobromide - 20mcg/actuation, Ipratropium bromide - 50mcg/actuation		Inhalation aerosol metered dose	544,256 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	L.L
C05CA03	DIOVENOR 600	B	Diosmin - 600mg	600mg	Tablet	544,256 L.L
C09CA07	MICARDIS	B	Telmisartan - 80mg	80mg	Tablet	998,475 L.L
L01AX03	TEMODAL	B	Temozolomide - 250mg	250mg	Capsule	18,516,505 L.L
L01EX10	RYDAPT	B	Midostaurin - 25mg	25mg	Capsule, soft	1,163,291,105 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	124,258,444 L.L
M01AH05	ARCOXIA	B	Etoricoxib - 90mg	90mg	Tablet, film coated	2,119,240 L.L